Has developed the first medical device to accurately assess middle ear infections so clinicians can determine when it is appropriate to prescribe antibiotics.
FDA STeP Program awarded to OtoNexus Medical Technologies for ultrasound platform technology that evaluates middle ear infections.
#MedicalInnovation#FDA#OtoNexus"
Join us at the FiRe Future in Review 2023 in Paso Robles, CA, as Caitlin Cameron, CEO, presents on AI & and GPT in Diagnostics on November 8th @ 2:00 p.m.
#ai#gpt#diagnostics
OtoNexus Medical Technologies is named as one of the top 3 companies by Keiretsu Mid Atlantic Forum at the recent Investor Capital Expo on October 25th, 2023.
Angel Capital Association Recognizes OtoNexus Medical Technologies as a Winner of Most Investable Company at the 2023 ACA Summit of Angel Investing https://t.co/yTw5I5wxen
OtoNexus Medical Technologies Honored as Top 100 Best Place to Work in Washington State, OtoNexus was one of just 25 Small Businesses selected. https://t.co/yTw5I5wxen
Exciting news! Accomplished life sciences leader Chris Rivera has joined the Board of Directors for OtoNexus Medical Technologies. His appointment strengthens the company's leadership and positions it for success. #HealthTech#BusinessAngels#AngelCapital#AngelNetwork
I am excited to share that Iโll be presenting OtoNexus at @KeiretsuForumโs Investor Capital Expo 2023 on April 06, 2023, at Microsoft, Redmond, WA. Join me to learn more about investing in medical device manufacturing. Register today! https://t.co/SZZBXaVCdw #Investing#startups
Exciting news! OtoNexus Medical Technologies awarded prestigious NSF Phase IIB Grant for its cutting-edge ultrasound platform technology. We are thrilled to have our groundbreaking technology recognized in this way. More info at https://t.co/mUYPbJssFZ #NSFgrants#healthTech
OtoNexus Medical Technologies has made the first device to assess middle ear infections so clinicians know when #antibiotics are appropriate. Watch their pitch video & like it for them to win the $10K #MedTechInnovator Best Video Award https://t.co/shRvcSMQm1
So happy Carol Perron has joined OtoNexus as VP of Marketing. She has been instrumental in the development of many new markets and successfully introduced numerous new medical devices to the market. Welcome, Carol!
OtoNexus Medical Technologies selected by the Southwest Pediatric Device Consortium Grant for the 2021-2022 program. The grant is sponsored by the Baylor College of Medicine Office of Research to support faculty members pilot clinical studies with novel pediatric medical devices.